GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,565,000 | -0.8% | 37,665 | -53.5% | 0.01% | 0.0% |
| Q2 2022 | $2,586,000 | -7.8% | 80,948 | 0.0% | 0.01% | +11.1% |
| Q1 2022 | $2,804,000 | +7.1% | 80,948 | -9.5% | 0.01% | +12.5% |
| Q4 2021 | $2,617,000 | +0.8% | 89,418 | -12.2% | 0.01% | 0.0% |
| Q3 2021 | $2,595,000 | +11.1% | 101,850 | +52.8% | 0.01% | 0.0% |
| Q2 2021 | $2,335,000 | +15.8% | 66,675 | +34.8% | 0.01% | +14.3% |
| Q1 2021 | $2,016,000 | +23.1% | 49,467 | +30.8% | 0.01% | +16.7% |
| Q4 2020 | $1,638,000 | -26.7% | 37,825 | -6.7% | 0.01% | -33.3% |
| Q3 2020 | $2,235,000 | -10.7% | 40,535 | +2.2% | 0.01% | -10.0% |
| Q2 2020 | $2,504,000 | +11.9% | 39,666 | -9.4% | 0.01% | -9.1% |
| Q1 2020 | $2,238,000 | -35.7% | 43,800 | 0.0% | 0.01% | -15.4% |
| Q4 2019 | $3,482,000 | +63.9% | 43,800 | 0.0% | 0.01% | +62.5% |
| Q3 2019 | $2,125,000 | – | 43,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |